The Phase 1 GALLOP study evaluating the investigational CAR-T therapy, CB-010, for treatment of lupus nephritis has launched.

Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vera Therapeutics (VERA – Research Report) today and set a price target of $75.00.

Patients with systemic lupus erythematosus and hydroxychloroquine-related retinal toxicity had a greater prevalence of antiretinal autoantibodies. Patients with systemic lupus erythematosus (SLE) and ...

In a report released today, Sami Corwin from William Blair maintained a Buy rating on Cabaletta Bio (CABA – Research Report). The company’s ...

A non-invasive diagnostic model, based partially on saliva samples, distinguished between patients with and without Sjögren’s ...

The following is a summary of “Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors,” published in the January 2025 issue of ...

Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative ...

The blood test for those at high risk of lung cancer could lead to earlier detection and a "major reduction" in deaths, a ...

Blood testing people at high risk of lung cancer could reduce the number of deaths, a study has found. University of St ...

Objective Juvenile SLE (jSLE) is an autoimmune disease characterised by the presence of high levels of autoantibodies, ...